Mercedes Robledo Selected Research

Mercedes Robledo Research Topics

Disease

84	Neoplasms (Cancer) 05/2024 - 08/2004
40	Paraganglioma (Paragangliomas) 04/2024 - 08/2002
28	Pheochromocytoma 04/2024 - 08/2013
16	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 04/2005
10	Neoplasm Metastasis (Metastasis) 12/2023 - 10/2014
9	Hypoxia (Hypoxemia) 12/2023 - 12/2010
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 11/2011
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2019 - 08/2012
3	Pituitary Neoplasms (Pituitary Adenoma) 05/2024 - 03/2007
3	Disease Progression 11/2023 - 01/2020
3	Carcinogenesis 01/2023 - 06/2015
3	Kidney Neoplasms (Kidney Cancer) 01/2023 - 05/2019
3	Melanoma (Melanoma, Malignant) 05/2019 - 01/2016
3	Multiple Endocrine Neoplasia Type 2a (MEN 2) 12/2017 - 01/2006
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2024 - 11/2006
2	Sarcoma (Soft Tissue Sarcoma) 12/2023 - 01/2023
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 02/2011
2	Adenoma (Adenomas) 01/2017 - 06/2007
2	Hyperplasia 01/2017 - 04/2005
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2015 - 01/2015
2	Carcinoma (Carcinomatosis) 02/2011 - 06/2007
2	T-Cell Lymphoma (Lymphoma, T Cell) 11/2007 - 08/2004
2	Lymphoma (Lymphomas) 11/2007 - 08/2004
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2007 - 08/2004
1	Acromegaly 05/2024
1	Pain (Aches) 04/2024
1	Hypertension (High Blood Pressure) 04/2024
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2020
1	Dwarfism 11/2020

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2002
17	Succinate Dehydrogenase (Fumarate Reductase)IBA 12/2023 - 04/2005
14	Biomarkers (Surrogate Marker)IBA 05/2024 - 09/2008
12	CatecholaminesIBA 04/2024 - 11/2014
12	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 08/2004
11	Messenger RNA (mRNA)IBA 01/2020 - 11/2007
8	MicroRNAs (MicroRNA)IBA 01/2022 - 02/2011
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 02/2011
6	Tyrosine Kinase InhibitorsIBA 11/2023 - 11/2011
6	EnzymesIBA 05/2022 - 11/2007
5	Phosphotransferases (Kinase)IBA 04/2023 - 08/2013
5	3-methoxytyramine (methoxytyramine)IBA 01/2023 - 04/2017
5	NormetanephrineIBA 01/2023 - 05/2012
5	MetanephrineIBA 01/2023 - 05/2012
4	Succinic Acid (Succinate)IBA 12/2023 - 10/2014
4	MTOR InhibitorsIBA 01/2023 - 11/2017
4	TubulinIBA 09/2012 - 04/2010
3	Epinephrine (Adrenaline)FDA LinkGeneric 12/2023 - 02/2015
3	Sunitinib (Sutent)FDA Link 11/2023 - 11/2011
3	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022 - 04/2017
3	FumaratesIBA 01/2019 - 10/2014
3	Myc associated factor XIBA 11/2014 - 06/2011
2	Sirolimus (Rapamycin)FDA Link 01/2023 - 05/2018
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2020 - 04/2019
2	endothelial PAS domain-containing protein 1IBA 01/2020 - 05/2019
2	Dopamine (Intropin)FDA LinkGeneric 04/2019 - 06/2016
2	Fumarate Hydratase (Fumarase)IBA 01/2019 - 05/2014
2	alpha-hydroxyglutarateIBA 01/2019 - 01/2019
2	Everolimus FDA Link 01/2018 - 01/2017
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2018 - 07/2012
2	Complementary DNA (cDNA)IBA 01/2018 - 07/2012
2	temsirolimus FDA Link 01/2018 - 11/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2017 - 01/2017
2	ParaffinIBA 01/2017 - 07/2012
2	RacivirIBA 01/2017 - 06/2007
2	SuspensionsIBA 01/2017 - 01/2015
2	Tumor Biomarkers (Tumor Markers)IBA 03/2016 - 08/2004
2	Cyclin-Dependent Kinase Inhibitor p27IBA 03/2012 - 06/2007
2	Cytochrome P-450 CYP3AIBA 11/2011 - 11/2007
1	Growth Hormone (Somatotropin)IBA 05/2024
1	Dopamine Agonists (Dopamine Agonist)IBA 05/2024
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 05/2024
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 05/2024
1	CannabinoidsIBA 04/2024
1	CannabidiolIBA 04/2024
1	Mitogen-Activated Protein KinasesIBA 12/2023
1	Temozolomide (Temodar)FDA LinkGeneric 11/2023
1	Radioisotopes (Radionuclides)IBA 11/2023
1	Dacarbazine (DIC)FDA LinkGeneric 11/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023
1	Vincristine (Oncovin)FDA LinkGeneric 11/2023
1	Imatinib Mesylate (Gleevec)FDA Link 01/2023
1	Deubiquitinating EnzymesIBA 01/2023
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023
1	somatostatin receptor 2IBA 01/2023
1	ProteomeIBA 01/2023
1	regorafenibIBA 01/2023
1	Circulating MicroRNAIBA 01/2022
1	Thyrotropin Alfa FDA LinkGeneric 01/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2021
1	xanthurenic acidIBA 06/2021
1	KynurenineIBA 06/2021
1	P-2 (P 2)IBA 06/2021
1	Inositol (Myoinositol)IBA 06/2021
1	Sialic AcidsIBA 06/2021
1	ChromatinIBA 11/2020
1	tryptophyltryptophanIBA 11/2020

Therapy/Procedure

13	Therapeutics 04/2024 - 11/2007
5	Drug Therapy (Chemotherapy) 11/2023 - 11/2006
3	Drug Tapering 01/2017 - 11/2011
2	Immunotherapy 02/2024 - 01/2023